Needle-Free Delivery Technology – assess products, developments, and revenue prospects What does the future hold for the needle-free delivery technology market? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.
Our 208 page report provides 97 tables, charts, and graphs covering 2 distinct submarket and 3 leading segments. Discover the most lucrative areas in the industry and the future market prospects. You will see financial results, interviews, trends, opportunities, and revenue predictions.
Forecasts from 2015-2025 and other analyses show you commercial prospects Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT), company profiles and commercial developments. Read the full transcript of five exclusive expert opinion interviews with industry specialists informing your understanding and allowing you to assess prospects for investments and sales: – Mr Mark Logomasini, Director of Business Development, Bioject Medical Technologies – Mr David Hoey, CEO, Vaxxas – Mr Chris Cappello, CTO, PharmaJet – Dr D F Chowdhury, CEO, Nemaura – Mr Robert E. Sievers, CEO and President, Aktiv-Dry LLC, and Professor, Department of Chemistry and Biochemistry, Center for Pharmaceutical Biotechnology, University of Colorado, Boulder
You will find prospects for key submarkets In addition to analyses of the overall world market, you will see revenue forecasting of 2 major submarkets and 3 leading segments to 2025: • Jet injectors
Our new study also provides qualitative analyses for each submarket identifying strengths, weaknesses, opportunities and potential threats to sales growth.
How will those needle-free delivery technology markets expand? Which applications will generate most money? This study will allow you to thoroughly understand the industry, finding the most promising places for investments and sales.
What are the prospects in the leading regions and countries? Events and progress worldwide will influence the market. In our study you will find individual revenue forecasts to 2025 for the leading regional and national markets: • US • Japan • Germany • France • UK • Spain • Italy • India • China • RoW
Many opportunities exist within the needle-free delivery technology market. Greater uptake of existing technology and products worldwide will also stimulate the industry and market. With our new investigation you will gain business research and analysis with individual sales predictions and discussions. You will find analysis of competition, as well as commercial drivers and restraints. See what is likely to achieve the most success.
Leading companies and potential for market growth Overall world revenue for the needle-free delivery technology market will reach $1.2bn in 2015, our work forecasts. We predict strong revenue growth from 2015 to 2025. Our work shows you what organisations hold greatest potential. See profiles of 6 leading companies and others, including these: • Antares Pharma • Zogenix • 3M • BD • PharmaJet • Bioject Medical Technologies
In general, a company profile gives you the following information: • Overview of the company, including its history in the needle-free delivery technology market • Discussion of a company’s activities and outlook including descriptions of leading products • Recent financial results • Assessment of recent developments – mergers and acquisitions (M&A), new products, and collaborations, inc. alliances, partnerships and joint ventures
What issues will affect the needle-free delivery technology market? Our new report discusses issues and events affecting the needle-free delivery technology market. You will find discussions, including qualitative analyses: • Increasing clinical evidence of product effectiveness • An increasing global diabetes population – providing bigger markets for needle-free delivery products • The emerging biological product and biosimilar market • The unmet needs for vaccination programmes • Continuous innovation and a strong R&D pipeline • Expansion internationally – targeting emerging economies
You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.
How the Needle-Free Delivery Technology Market Forecast 2015-2025: Opportunities for Leading Companies report helps you In summary, our 208 page report gives you the following knowledge: • Revenues forecasts to 2025 for the overall world needle-free delivery technology market, 2 submarkets and 3 leading segments – discover the industry’s prospects, finding promising places for investments and revenues • Assessment of leading companies, and others, discovering activities and outlooks • Market forecasting to 2025 for the leading regional and national markets – US, Japan, Germany, France, UK, Spain, Italy, India, China and RoW. • View opinions from our survey, seeing interviews with authorities • Investigation of competition and opportunities influencing sales • Discussion of what stimulates and restrains the needle-free delivery technology market
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunity. See there how you could benefit your research, analyses, and decisions. Also see how you can save time and get recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the needle-free delivery technology market. You find data, trends and predictions. Please order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Global Needle-Free Delivery Technology Market Overview 1.2 Overview of Findings 1.3 Structure of the Report 1.4 Global Needle-Free Delivery Technology Market Segmentation 1.5 Why You Should Read This Report 1.6 How This Report Delivers 1.7 Key Questions Answered by This Analytical Report 1.8 Who is This Report For? 1.9 Methodology 1.10 Frequently Asked Questions (FAQ) 1.11 Associated Visiongain Reports 1.12 About Visiongain
2. Introduction to Needle-Free Delivery Technology 2.1 What is Needle-Free Delivery Technology? 2.1.1 Needlestick Injury 2.1.1.1 Blood-Borne Pathogens and Needlestick Injury 2.1.1.2 Accidental Needlestick Injury: A Serious Healthcare Problem 2.2 The Needle-Free Delivery Technology Market 2.3 Jet Injectors 2.3.1 Concerns about Multi-use Nozzle Jet injectors (MUNJIs) 2.3.2 Strengths and Weaknesses of Jet Injectors 2.4 Competing Needle-Free Technologies 2.4.1 Novel Needle Technology 2.4.1.1 Pen Needles 2.4.1.2 Microneedles 2.4.1.3 Hollow Microneedles 2.4.1.4 Solid Coated Microneedles 2.4.1.5 Solid Biodegradable Microneedles 2.4.1.6 Solid Uncoated Microneedles 2.4.1.7 Selection of Microneedles 2.4.2 Inhaler Technology 2.4.3 Transdermal Patch Technology 2.5 Clinical Settings Where Needle-Free Delivery Technology Will Be Beneficial 2.5.1 Pain Management 2.5.1.1 Using Needle-Free Injection Devices to Administer Lidocaine 2.5.2 Vaccine Delivery: Improving Immune Response 2.5.2.1 Needle-Free Vaccine Delivery 2.5.2.2 Mass Immunisation 2.5.3 Insulin Delivery for Diabetics 2.5.4 Paediatric Injections 2.5.5 Other Uses for Needle-Free Injection Technology 2.6 Regulation of the Needle-Free Delivery Technology Market 2.6.1 The US Regulation System 2.6.1.1 Combination Products 2.6.1.2 FDA Statement Clamps Down On Delivery of Medications in Non-approved Needle-Free Devices 2.6.2 The European Regulation System 2.6.2.1 Post Marketing Surveillance in the EU
3. Needle-Free Delivery Technology: World Market 2015-2025 3.1 The Needle-Free Delivery Technology Market: Overview 3.2 Needle-Free Delivery Technology Market Segmentation, 2014 3.3 The Needle-Free Delivery Technology Market Forecast, 2015-2025 3.4 How Will Segmental Market Shares Change to 2025? 3.5 Needle-Free Delivery Technology: Market Trends, 2015-2025 3.6 Needle-Free Delivery Technology: Drivers and Restraints 2015-2025
4. Jet Injectors Technology Market, 2015-2025 4.1 The Jet Injectors Market Overview 4.2 Jet Injectors: Market Forecast 2015-2025 4.3 Jet Injector Devices on the Market 4.3.1 Biojector 2000 (Bioject Medical Technologies) 4.3.2 ZetaJet (Bioject Medical Technologies) 4.3.3 Vision (Antares Pharma) 4.3.4 Vibex (Antares Pharma) 4.3.5 Sumavel DosePro (Endo International) 4.3.6 Stratis (PharmaJet) 4.3.7 LectraJet (D’Antonio Consultants International) 4.3.8 AdvantaJet and GentleJet (Activa Brand Products) 4.3.9 Vitajet (Bioject Medical Technologies) 4.3.10 Med-Jet (Medical International Technologies) 4.3.11 J-Tip (National Medical Products) 4.3.12 Injex30 (Injex Pharma) 4.3.13 SQ-Pen, SQ-X and MHP-1 (Bespak) 4.3.14 E-Jet 100 (Eurojet Medical) 4.3.15 Penjet (Penjet Corporation) 4.4 Jet Injectors Development Pipeline 4.4.1 Glide SDI (Glide Pharmaceutical Technologies) 4.4.2 Zeneo (Crossject) 4.4.3 Relday (Zogenix) 4.4.4 Magnetic Injection (Massachusetts Institute of Technology) 4.4.5 Intradermal (ID) Pen (Bioject Medical Technologies) 4.4.6 Iject and Iject R (Bioject Medical Technologies) 4.4.7 Jupiter Jet (Bioject Medical Technologies)
5. Competing Needle-Free Technology Market, 2015-2025 5.1 The Competing Needle-Free Technology Overview 5.2 The Competing Technology: Market Forecast 2015-2025 5.3 How Will Segmental Market Shares Change to 2025? 5.4 Novel Needle Technology Overview 5.5 Novel Needle Technology: Market Forecast, 2015-2025 5.5.1 Leading Novel Needle Technologies 5.5.1.1 Soluvia Microinjection System (BD) 5.5.1.2 Ultra-Fine Nano 4mm Pen Needle (BD) 5.5.1.3 AutoShield Duo Pen Needle (BD) 5.5.1.4 Microstructured Transdermal Systems (3M) 5.5.1.5 ZP Patch Technology (Zosano) 5.5.2 Novel Needle Technology Development Pipeline 5.5.2.1 Microneedle Patch (Georgia Institute of Technology) 5.5.2.2 Micronjet (NanoPass) 5.5.2.3 DebioJect (Debiotech) 5.5.2.4 AdminPen (nanoBioSciences) 5.5.2.5 PKA SoftTouch (PKA SoftTouch Corp) 5.5.2.6 DrugMat and VaxMat (TheraJect) 5.5.2.7 MicroCor (Corium International) 5.5.2.8 Nanopatch (Vaxxas) 5.5.2.9 Nanotopography Enhanced Microneedle Delivery (University of California-San Francisco, Georgia Institute of Technology and Kimberly-Clark) 5.5.2.10 Memspatch and Micro-Patch (Nemaura) 5.5.2.11 Microneedle Patch for Lidocaine Delivering (National University of Singapore) 5.6 Inhaler Technology Overview 5.7 Inhaler Technology: Market Forecast, 2015-2025 5.7.1 Inhaler Products in the Asthma Market 5.7.1.1 Preventer Inhalers 5.7.1.2 Reliever Inhalers 5.7.2 Inhaler Products in the Insulin Market 5.7.2.1 Afrezza (MannKind) 5.7.3 Inhaler Products in the Vaccine Market 5.7.3.1 FluMist Quadrivalent (MedImmune) 5.7.4 Vaccine Inhaler Pipeline 5.8 Transdermal Patch Technology Overview 5.9 Transdermal Patch Technology: Market Forecast, 2015-2025 5.9.1 Selected Transdermal Patch Products 5.9.1.1 Duragesic (Fentanyl, Janssen Pharmaceuticals) 5.9.1.2 Nicoderm CQ (Nicotine, GlaxoSmithKline) 5.9.1.3 Exelon Patch (Rivastigmine, Novartis) 5.9.1.4 Zecuity (Sumatriptan, Teva) 5.9.2 Transdermal Patch Technology Development Pipeline 5.9.2.1 Electronic Transdermal Patch (Rhenovia Pharma) 5.9.2.2 Electroporation-Mediated DNA Drug Delivery (TriGrid, Ichor Medical Systems) 5.9.2.3 Ultrasonic Waveforms (U-Strip, Transdermal Specialties) 5.9.2.4 Prelude SkinPrep System (Echo Therapeutics) 5.10 Other Competing Needle-free delivery Technology in development 5.10.1 Microbubbles Injection (Shibaura Institute of Technology) 5.10.2 Laser Injection (Seoul National University) 5.10.3 Vaccine Delivery Using Micro-Shock Waves (Indian Institute of Science, Bangalore) 5.10.4 Nanotechnology Syringes (Gwangju Institute of Science and Technology, South Korea)
6. Leading National Markets 2015-2025 6.1 National Breakdown of the World Needle-Free Technology Market 6.2 World Needle-Free Delivery Technology Market: Regional Forecast 2015-2025 6.2.1 How Will Regional Market Shares Change to 2025? 6.3 The US Needle-Free Delivery Technology Market 2015-2025 6.3.1 US Needle-Free Delivery Technology Market Forecast 2015-2025 6.3.2 FDA Guideline for Combination Products 6.3.3 Needle-Free Delivery and the US Flu Vaccination Market 6.3.4 Measles Outbreak in the US 6.4 The EU5 Needle-Free Delivery Technology Market 2015-2025 6.4.1 EU5 Needle-Free Delivery Technology Market Forecast 2015-2025 6.4.2 The German Needle-Free Delivery Technology Market Forecast, 2015-2025 6.4.3 The French Needle-Free Delivery Technology Market Forecast, 2015-2025 6.4.4 The UK Needle-Free Delivery Technology Market Forecast, 2015-2025 6.4.5 The Italian Needle-Free Delivery Technology Market Forecast, 2015-2025 6.4.6 The Spanish Needle-Free Delivery Technology Market Forecast, 2015-2025 6.5 The Japanese Needle-Free Delivery Technology Market 2015-2025 6.5.1 Japanese Needle-Free Delivery Technology Market Forecast 2015-2025 6.6 The Chinese Needle-Free Delivery Technology Market 2015-2025 6.6.1 Chinese Needle-Free Delivery Technology Market Forecast 2015-2025 6.7 The Indian Needle-Free Delivery Technology Market 2015-2025 6.7.1 Indian Needle-Free Delivery Technology Market Forecast 2015-2025 6.7.2 Needles and Syringes Being reused in Indian Hospitals
7. Leading Companies in the Needle-Free Delivery Technology Market 7.1 Leading Needle-Free Delivery Technology Manufacturers in 2014 7.2 Antares Pharma 7.2.1 Antares Pharma: Needle-Free Delivery Technology Product Portfolio 7.2.2 Antares Pharma: Financial Overview 7.2.3 Antares Pharma: Products in Development 7.2.4 Settlement of Patent Infringement Case between Antares Pharma and Medac Pharma 7.3 Zogenix 7.3.1 Zogenix: Product Portfolio 7.3.2 Zogenix: Current Pipeline 7.3.3 Zogenix: Financial Overview 7.4 3M 7.4.1 3M: Needle-Free Delivery Technology Product Portfolio 7.4.1.1 3M: Metered Dose Inhaler 7.4.1.2 3M: Transdermal patch 7.4.1.3 3M: Microneedle 7.4.2 3M: Financial Overview 7.5 BD 7.5.1 BD: Needle-Free Delivery Technology Product Portfolio 7.5.2 BD: Financial Overview 7.5.3 Recall of BD Needles in HongKong 7.6 PharmaJet 7.6.1 PharmaJet: Needle-Free Delivery Technology Product Portfolio 7.6.2 First FDA Approved Jet Injector for Flu Shot in the US 7.6.3 PharmaJet: Collaborations and Needle-Free Delivery Technology Pipeline 7.6.4 Preference for PharmaJet over Needle and Syringe 7.7 Bioject Medical Technologies 7.7.1 Bioject Medical Technologies: Needle-Free Delivery Technology Product Portfolio and Pipeline 7.7.2 Bioject Medical Technologies: Financial Overview 7.7.3 Focusing on Developing Countries
8. Qualitative Analysis of the Needle-Free Delivery Technology Market 2015-2025 8.1 SWOT Analysis of the Needle-Free Delivery Technology Market 8.2 Strengths 8.2.1 Strong Growth in the Biologic Drug Market 8.2.2 Increasing Development in Transdermal Delivery 8.2.3 No Specialist Training Required and No Needlestick Injuries 8.2.4 Eliminating the Cold Chain Problem 8.3 Weaknesses 8.3.1 Healthcare Practitioners are not Familiar with Novel Delivery Systems 8.3.2 Greater Regulatory Scrutiny 8.3.3 Inefficient Manufacturing Processes 8.4 Opportunities 8.4.1 Emerging Economies Offer Significant Growth Opportunities 8.4.2 Mass Immunisation Programmes around the World 8.4.3 Increasing Global Diabetes Population 8.4.4 Shift towards Home Administration Setting 8.4.5 Extending Life Cycle of Drugs 8.5 Threats 8.5.1 Traditional Needles and Syringes are Very Cheap to Mass Produce 8.5.2 Needle and Syringes with Anti Needlestick Injury Technology 8.5.3 Limited Clinical Data 8.5.4 Medical Device Excise Tax
9. Research Interviews 9.1 Interview with Mark Logomasini, Director of Business Development, Bioject Medical Technologies 9.1.1 The Spring-Powered, Gas-Powered and Battery Powered Jet Injector Markets 9.1.2 Other Competing Needle-Free Delivery Platforms 9.1.3 Regulations Determine Jet Injector Market 9.1.4 Small Needle Free Delivery Companies Requires Large External Capital 9.2 Interview with David Hoey, CEO, Vaxxas 9.2.1 Vaxxas’s Nanopatch Technology 9.2.2 The Advantages of Using Nanopatch Technology in Developed and Developing Markets 9.2.3 The Challenges of Manufacturing Patch Technology 9.2.4 The Future for the Nanopatch Technology 9.3 Interview with Chris Cappello, CTO, PharmaJet 9.3.1 On Current Collaborations 9.3.2 On potential Competitors and the restraint in the market 9.3.3 The Application of Microneedles and transdermal patches is still limited 9.3.4 On Future Growth of the Jet Injector Market 9.4 Interview with John Turanin, Vice President and General Manager, Zogenix Technologies 9.4.1 The Use of Gas Power in Jet Injectors 9.4.2 The Incentives for Drug Companies in Adopting Needle-Free Delivery 9.4.3 Regulating the Needle-Free Delivery Technology Market 9.4.4 Regional Market Forecasts for Jet Injectors 9.4.5 Jet Injectors: Competitive Space and Restraints on the Market 9.5 Interview with Dr D F Chowdhury, CEO, Nemaura 9.5.1 Current Development of Nemaura 9.5.2 Patented Skin Delivery Platforms 9.5.3 Greatest Restraint: Regulatory Barriers 9.5.4 Advantages over Other Technologies 9.5.5 On Future Trends for the Patch and Microneedle Market 9.6 Interview with Robert E. Sievers, CEO and President, Aktiv-Dry LLC, and Professor, Department of Chemistry and Biochemistry, Center for Pharmaceutical Biotechnology, University of Colorado, Boulder 9.6.1 Aktiv-Dry's PuffHaler 9.6.2 The Benefits of Inhaler Technology 9.6.3 The Competitive Landscape for Measles Inhaler Vaccines 9.6.4 ACTIV DRY’S Collaborations 9.6.5 The Challenges to Introduction Novel Inhaler Technology
10. Conclusions 10.1 The World Needle-Free Technology Market in 2014 and 2015 10.1.1 Current Leading Needle-Free Technology Segments 10.1.2 Notable Needle-Free Technology Companies 10.1.3 Leading Regional Markets 10.2 World Needle-Free Technology Market Forecast 2015-2025 10.3 The Future of the Needle-Free Technology Market? 10.3.1 Biosimilars are a Major Driver of the Needle Free Delivery Market 10.3.2 Strong Pipeline Will Drive the Competing Needle-Free Injection Technology Market
List of Tables Table 1.1 Leading National Needle-Free Delivery Technology Market Forecast 2015-2025 ($m, AGR%, CAGR%) Table 2.1 Classification of Jet Injectors by Method of Propulsion Table 2.2 Strengths and Weaknesses of the Jet Injector Market Table 2.3 Pen Needle Technology by Needle Length Table 2.4 Rationale For Needle-Free Vaccine Delivery Table 2.5 Examples of Needle-Free Vaccine Delivery Systems, 2015 Table 2.6 Examples of Needle-Free Insulin Delivery Systems for Diabetics, 2015 Table 2.7 FDA Guidance on Regulation of Needle-Free Injectors, 2015 Table 3.1 The Needle-Free Delivery Technology Market: Revenue ($m), Market Share (%) by Segment, 2014 Table 3.2 The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025 Table 4.1 The Jet Injectors Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025 Table 5.1 The Competing Needle-Free Technology Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025 Table 5.2 Novel Needle Technology Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025 Table 5.3 Inhaler Technology Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025 Table 5.4 Leading Products in the Asthma Preventer Inhaler Market, 2015 Table 5.5 Leading Products in the Asthma Reliever Inhaler Market, 2015 Table 5.6 Insulin Inhalers Withdrawal from the Market or Pipeline, 2015 Table 5.7 Vaccine Inhalers Currently Under Development, 2015 Table 5.8 Transdermal Patch Technology Market: Revenue ($m), AGR (%), CAGR (%), 2014-2025 Table 5.9 Transdermal Patch Products, 2015 Table 6.1 World Needle-Free Delivery Technology Market: Revenues ($m) by Region, 2014 and 2015 Table 6.2 World Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%) by Region, 2014-2025 Table 6.3 US Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025 Table 6.4 EU5 Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025 Table 6.5 German Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025 Table 6.6 French Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025 Table 6.7 UK Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025 Table 6.8 Italian Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025 Table 6.9 Spanish Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025 Table 6.10 Japanese Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025 Table 6.11 Chinese Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025 Table 6.12 Indian Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), CAGR (%), 2014-2025 Table 7.1 Antares Pharma: Overview, 2015 Table 7.2 Antares Pharma: Product Portfolio 2015 Table 7.3 Antares’ Revenue ($m) from Major Customers, 2010-2014 Table 7.4 Antares Pharma: Revenue ($m), AGR (%), CAGR (%), 2010-2014 Table 7.5 Antares Pharma: Products in Development 2015 Table 7.6 Zogenix: Overview, 2015 Table 7.7 Zogenix: Revenue ($m), AGR (%), CAGR (%), 2010-2014 Table 7.8 Zogenix: Revenue ($m) by Type, 2010-2014 Table 7.9 3M: Overview, 2015 Table 7.10 3M: Diabetes Care Revenue ($m), AGR (%), CAGR (%), 2009-2014 Table 7.11 BD: Overview, 2015 Table 7.12 BD: Needle-Free Delivery Technology Product Portfolio 2015 Table 7.13 BD: Revenue ($bn) by Geographic Region, 2012-2014 Table 7.14 BD: Diabetes Care Revenue ($m), AGR (%), CAGR (%), 2009-2014 Table 7.15 PharmaJet: Overview, 2015 Table 7.16 Bioject Medical Technologies: Overview, 2015 Table 7.17 Bioject Medical Technologies: Revenue ($m) by Product Line, 2010 Table 7.18 Bioject Medical Technologies: Revenue ($m), AGR (%), CAGR (%), 2010-2014 Table 8.1 SWOT Analysis of the Needle-Free Delivery Technology Market, 2015-2025 Table 8.2 Average Price For Needle-Free Drug/Vaccine Delivery Technology, 2014
List of Figures Figure 1.1 Indian Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025 Figure 1.2 Global Needle-Free Delivery Technology Market Segmentation Overview, 2015 Figure 2.1 Percentage (%) of Needlestick Injuries During the Timeline of Use to Disposal of a Device Figure 3.1 The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%), 2014-2025 Figure 3.2 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2014 Figure 3.3 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2019 Figure 3.4 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2025 Figure 3.5 Needle-Free Delivery Technology: Drivers and Restraints 2015-2025 Figure 4.1 The Jet Injectors Market: Revenue ($m), AGR (%), 2014-2025 Figure 5.1 The Competing Needle-Free Technology Market: Revenue ($m), AGR (%), 2014-2025 Figure 5.2 Market Shares (%) of Competing Needle-Free Technology Market Segments, 2014 Figure 5.3 Market Shares (%) of Competing Needle-Free Technology Market Segments, 2019 Figure 5.4 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2025 Figure 5.5 Novel Needle Technology Market: Revenue ($m), AGR (%), 2014-2025 Figure 5.6 Inhaler Technology Market: Revenue ($m), AGR (%), 2014-2025 Figure 5.7 Transdermal Patch Technology Market: Revenue ($m), AGR (%), 2014-2025 Figure 6.1 World Needle-Free Delivery Technology Market: Revenues ($m) by Region, 2014 Figure 6.2 World Needle-Free Delivery Technology Market: Revenues ($m) by Region, 2015 Figure 6.3 World Needle-Free Delivery Technology Market: Revenues ($m) by Region, 2014-2025 Figure 6.4 World Needle-Free Delivery Technology Market: Market Shares (%) by Regional Market, 2014 Figure 6.5 World Needle-Free Delivery Technology Market: Market Shares (%) by Regional Market, 2019 Figure 6.6 World Needle-Free Delivery Technology Market: Market Shares (%) by Regional Market, 2025 Figure 6.7 US Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025 Figure 6.8 EU5 Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025 Figure 6.9 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2014 Figure 6.10 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2019 Figure 6.11 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2025 Figure 6.12 German Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025 Figure 6.13 French Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025 Figure 6.14 UK Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025 Figure 6.15 Italian Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025 Figure 6.16 Spanish Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025 Figure 6.17 Japanese Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025 Figure 6.18 Chinese Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025 Figure 6.19 Indian Needle-Free Delivery Technology Market Forecast: Revenues ($m), AGR (%), 2014-2025 Figure 7.1 Antares’ Revenue from Major Customers, 2010-2014 Figure 7.2 Antares Pharma: Revenue ($m), AGR (%), 2010-2014 Figure 7.3 Zogenix: Revenue ($m), AGR (%), 2010-2014 Figure 7.4 Zogenix: Revenue ($m) by Type, 2010-2014 Figure 7.5 3M: Diabetes Care Revenue ($m), AGR (%), 2009-2014 Figure 7.6 BD: Revenue ($bn) by Geographic Region, 2012-2014 Figure 7.7 BD: Diabetes Care Revenue ($m), AGR (%), 2009-2014 Figure 7.8 Bioject Medical Technologies: Revenue Share (%) by Product Line, 2010 Figure 7.9 Bioject Medical Technologies: Revenue ($m), AGR (%), 2010-2014 Figure 8.1 The Transport Process For a Vaccine
3M Actavis Activa Brand Products AcuShot Adamis Aktiv-Dry Alkermes Alza Anesiva Antares Pharma Aradigm Astellas Pharma AstraZeneca BD BeadTek Berlex Labs Bespak bioCSL Bioject Medical Technologies Biomedics Boehringer Ingelheim Bristol-Myers Squibb and Somerset Pharmaceuticals Cambridge Consultants CareFusion Corporation CEA-LETI Corium International CosMed Crossject CureVac D’Antonio Consultants International Debiotech Durect Echo Therapeutics Elcam Medical Eli Lilly & Co Endo International Ethical Holdings/Schering Eurojet Medical Ferndale Georgia Institute of Technology Giant Eagle GlaxoSmithKline Glide Pharmaceutical Technologies Hangzhou Hema Medical Equipment Haselmeir GmbH Health-Mor Personal Care Hirtenberger Ichor iHealthNet Immunomic Therapeutics ImmusanT Injex Pharma Invion Janssen Pharmaceuticals Key Pharmaceuticals Kroger LEO Pharma LTS Lohmann Therapie-Systeme MannKind Mecaplast Meda Pharmaceuticals Medac Pharma Medical International Technologies Medi-Ject MedImmune Merck Merck Serono Micron Biomedical Mylan nanoBioSciences NanoPass Napp Pharmaceuticals National Medical Products Nektar Therapeutics Nemaura Nicobrand Limited Novartis Novo Nordisk Novogyne Pharmaceuticals NuPathe Nycomed Ortho-McNeil Owen MumFord Inc Par Pharmaceutical Parke-Davis Penjet Corporation Pernix Pfizer PharmaJet PKA SoftTouch Corp Procter & Gamble ProStrakan Purdue Pharma Radius Health Rhenovia Pharma Rite Aid Roche Sandoz Sanofi Searle Pharmaceuticals Shire SHL Group AB Shwarz-Pharma Société Nationale des Poudres et Explosifs STADA Arzneimittel AG Stat Medical Devices Takeda Teva The Medical House TheraJect TheraTech Transdermal Specialties Trimeris Trinity-Chiesi UCB Pharma University of California-San Francisco Vaxxas Vetter Pharma Vyteris Watson West Pharmaceuticals Westmount Pharmacy Ypsomed AG Zogenix Zosano Zydus Cadila
Other Organisations Mentioned in This Report Ankara University Atlanta’s Emory University Bill & Melinda Gates Foundation Gwangju Institute of Science and Technology Indian Institute of Science, Bangalore Massachusetts Institute of Technology National University of Singapore Oxford University Seoul National University Shibaura Institute of Technology University of Texas University of Wisconsin’s Hospital
Download sample pages
Complete the form below to download your free sample pages for Needle-Free Delivery Technology Market Forecast 2015-2025
Download sample pages
Complete the form below to download your free sample pages for Needle-Free Delivery Technology Market Forecast 2015-2025
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.
Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions.
Visiongain Publishes Next Generation Sequencing Market Report 2021-2031
Rising preference for personalised medicine in developed as well as developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase NGS market concentration over the forecast period.
The rising frequency of bacterial and viral diseases coupled with increased focus on immunisation programmes are two main reasons that are expected to boost the global anti-infective vaccines market’s growth in the coming years.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
